Prospects for potential therapy targeting immune‑associated factors in endometriosis (Review)
- Authors:
- Wenwen Zhang
- Kang Li
- Aiwen Jian
- Guanran Zhang
- Xiaoli Zhang
-
Affiliations: Key Laboratory for Experimental Teratology of Ministry of Education, Department of Histology and Embryology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong 250012, P.R. China - Published online on: December 23, 2024 https://doi.org/10.3892/mmr.2024.13422
- Article Number: 57
-
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
|
Zondervan KT, Becker CM and Missmer SA: Endometriosis. N Engl J Med. 382:1244–1256. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Taylor HS, Kotlyar AM and Flores VA: Endometriosis is a chronic systemic disease: Clinical challenges and novel innovations. Lancet. 397:839–582. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Williams EA: Endometriosis in Clinical-practice-surgical aspects. Irish J Med Sci. 152:14–17. 1983. View Article : Google Scholar : PubMed/NCBI | |
|
Van Gorp T, Amant F, Neven P, Vergote I and Moerman P: Endometriosis and the development of malignant tumours of the pelvis. A review of literature. Best Pract Res Clin Obstet Gynaecol. 18:349–371. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Indrielle-Kelly T, Fruhauf F, Burgetova A, Fanta M and Fischerova D: Diagnosis of endometriosis 3rd Part-ultrasound diagnosis of deep endometriosis. Ceska Gynekol. 84:269–275. 2019.PubMed/NCBI | |
|
Fukunaga M, Nomura K, Ishikawa E and Ushigome S: Ovarian atypical endometriosis: Its close association with malignant epithelial tumours. Histopathology. 30:249–255. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, et al: Association between endometriosis and risk of histological subtypes of ovarian cancer: A pooled analysis of case-control studies. Lancet Oncol. 13:385–394. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
He Y, Cao B and Huang Y: Effect of endometriosis on prognosis of ovarian clear cell carcinoma: A 10-year retrospective study. Front Oncol. 14:14383092024. View Article : Google Scholar : PubMed/NCBI | |
|
Anglesio MS, Bashashati A, Wang YK, Senz J, Ha G, Yang W, Aniba MR, Prentice LM, Farahani H, Li Chang H, et al: Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden. J Pathol. 236:201–209. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Czernobilsky B and Morris WJ: A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes. Obstet Gynecol. 53:318–323. 1979.PubMed/NCBI | |
|
LaGrenade A and Silverberg SG: Ovarian tumors associated with atypical endometriosis. Hum Pathol. 19:1080–1084. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Nouri B, Hashemi SH, J Ghadimi D, Roshandel S and Akhlaghdoust M: Machine Learning-based detection of endometriosis: A retrospective study in a population of iranian female patients. Int J Fertil Steril. 18:362–366. 2024.PubMed/NCBI | |
|
Moradi Y, Shams-Beyranvand M, Khateri S, Gharahjeh S, Tehrani S, Varse F, Tiyuri A and Najmi Z: A systematic review on the prevalence of endometriosis in women. Indian J Med Res. 154:446–454. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Mafra F, Catto M, Bianco B, Barbosa CP and Christofolini D: Association of Wnt4 polymorphisms with endometriosis in infertile patients. J Assist Reprod Genet. 32:1359–1364. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Santulli P, Bourdon M, Presse M, Gayet V, Marcellin L, Prunet C, de Ziegler D and Chapron C: Endometriosis-Related infertility: Assisted reproductive technology has no adverse impact on pain or quality-of-life scores. Fertil Steril. 105:978–987.e4. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ferrero S, Stabilini C, Barra F, Clarizia R, Roviglione G and Ceccaroni M: Bowel resection for intestinal endometriosis. Best Pract Res Clin Obstet Gynaecol. 71:114–128. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Chapron C, Marcellin L, Borghese B and Santulli P: Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 15:666–682. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ferrero S, Barra F, Scala C and Condous G: Ultrasonography for bowel endometriosis. Best Pract Res Clin Obstet Gynaecol. 71:38–50. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Geng JH and Lee YC: Bladder endometriosis. N Engl J Med. 381:e432019. View Article : Google Scholar : PubMed/NCBI | |
|
Santulli P, Marcellin L, Tosti C, Chouzenoux S, Cerles O, Borghese B, Batteux F and Chapron C: MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis? Expert Opin Ther Targets. 19:1465–1483. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Brown J, Crawford TJ, Allen C, Hopewell S and Prentice A: Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev. 1:CD0047532017.PubMed/NCBI | |
|
Streuli I, de Ziegler D, Santulli P, Marcellin L, Borghese B, Batteux F and Chapron C: An update on the pharmacological management of endometriosis. Expert Opin Pharmacother. 14:291–305. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wu Y, Liu Y, Jia H, Luo C and Chen H: Treatment of endometriosis with dienogest in combination with traditional Chinese medicine: A systematic review and meta-analysis. Front Surg. 9:9924902022. View Article : Google Scholar : PubMed/NCBI | |
|
Chinese Medical Association Obstetrics, Gynecology Branch, Endometriosis Professional Committee and Chinese Medical Association Obstetrics and Gynecology Branch Endometriosis Collaborative Group, . Long-term management of endometriosis: Chinese expert consensus. Chin J Obstet Gynecol. 53:836–841. 2018.(In Chinese). | |
|
Endometriosis Collaborative Group of the Obstetrics and Gynecology Branch of the Chinese Medical Association, . Guidelines for the diagnosis and treatment of endometriosis. Chin J Obstet Gynecol. 3:161–169. 2015. | |
|
Vercellini P, Viganò P, Somigliana E and Fedele L: Endometriosis: Pathogenesis and treatment. Nat Rev Endocrinol. 10:261–275. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Barbieri RL: Stenosis of the external cervical os: An association with endometriosis in women with chronic pelvic pain. Fertil Steril. 70:571–573. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Sanfilippo JS, Wakim NG, Schikler KN and Yussman MA: Endometriosis in Association with Uterine Anomaly. Am J Obstet Gynecol. 154:39–43. 1986. View Article : Google Scholar : PubMed/NCBI | |
|
Halme J, Hammond MG, Hulka JF, Raj SG and Talbert LM: Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol. 64:151–154. 1984.PubMed/NCBI | |
|
Herington JL, Bruner-Tran KL, Lucas JA and Osteen KG: Immune interactions in endometriosis. Expert Rev Clin Immunol. 7:611–626. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kyama CM, Debrock S, Mwenda JM and D'Hooghe TM: Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol. 1:1232003. View Article : Google Scholar : PubMed/NCBI | |
|
Christodoulakos G, Augoulea A, Lambrinoudaki I, Sioulas V and Creatsas G: Pathogenesis of endometriosis: The role of defective ‘immunosurveillance’. Eur J Contracept Reprod Health Care. 12:194–202. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Koninckx PR, Ussia A, Adamyan L, Wattiez A, Gomel V and Martin DC: Pathogenesis of endometriosis: The Genetic/Epigenetic theory. Fertil Steril. 111:327–340. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Foster WG: Hypoxia-induced autophagy, epithelial to mesenchymal transition, and invasion in the pathophysiology of endometriosis: A perspective. Biol Reprod. 99:905–906. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Tanbo T and Fedorcsak P: Endometriosis-associated infertility: Aspects of pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand. 96:659–667. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Gibson DA, Simitsidellis I, Collins F and Saunders PTK: Androgens, oestrogens and endometrium: A fine balance between perfection and pathology. J Endocrinol. 246:R75–R93. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Mohammed Rasheed HA and Hamid P: Inflammation to infertility: Panoramic view on endometriosis. Cureus. 12:e115162020.PubMed/NCBI | |
|
Halis G and Arici A: Endometriosis and Inflammation in Infertility. Ann N Y Acad Sci. 1034:300–315. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Kang YJ, Jeung IC, Park A, Park YJ, Jung H, Kim TD, Lee HG, Choi I and Yoon SR: An increased level of IL-6 suppresses NK cell activity in peritoneal fluid of patients with endometriosis via regulation of SHP-2 expression. Hum Reprod. 29:2176–2189. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR and Agarwal A: Prediction of endometriosis with serum and peritoneal fluid markers: A prospective controlled trial. Hum Reprod. 17:426–431. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Vilas Boas L, Bezerra Sobrinho C, Rahal D, Augusto Capellari C, Skare T and Nisihara R: Antinuclear antibodies in patients with endometriosis: A cross-sectional study in 94 patients. Hum Immunol. 83:70–73. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Dias JA Jr, de Oliveira RM and Abrao MS: Antinuclear antibodies and endometriosis. Int J Gynaecol Obstet. 93:262–263. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Malinowski A, Szpakowski M, Wilczynski J, Banasik M and Puchala B: Occurrence of antinuclear antibodies in women with endometriosis and unexplained infertility. Ginekol Pol. 66:420–424. 1995.(In Polish). PubMed/NCBI | |
|
Swann JB and Smyth MJ: Immune surveillance of tumors. J Clin Invest. 117:1137–1146. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Vallve-Juanico J, Houshdaran S and Giudice LC: The endometrial immune environment of women with endometriosis. Hum Reprod Update. 25:564–591. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Podgaec S, Abrao MS, Dias JA Jr, Rizzo LV, de Oliveira RM and Baracat EC: Endometriosis: An inflammatory disease with a Th2 immune response component. Hum Reprod. 22:1373–1379. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Olkowska-Truchanowicz J, Bocian K, Maksym RB, Bialoszewska A, Wlodarczyk D, Baranowski W, Ząbek J, Korczak-Kowalska G and Malejczyk J: CD4+ CD25+ FOXP3+ regulatory T cells in peripheral blood and peritoneal fluid of patients with endometriosis. Hum Reprod. 28:119–124. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tanaka E, Sendo F, Kawagoe S and Hiroi M: Decreased natural killer cell activity in women with endometriosis. Gynecol Obstet Invest. 34:27–30. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Thiruchelvam U, Wingfield M and O'Farrelly C: Natural killer cells: Key players in endometriosis. Am J Reprod Immunol. 74:291–301. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Sciezynska A, Komorowski M, Soszynska M and Malejczyk J: Nk cells as potential targets for immunotherapy in endometriosis. J Clin Med. 8:172019. View Article : Google Scholar | |
|
Artemova D, Vishnyakova P, Khashchenko E, Elchaninov A, Sukhikh G and Fatkhudinov T: Endometriosis and cancer: Exploring the role of macrophages. Int J Mol Sci. 22:51962021. View Article : Google Scholar : PubMed/NCBI | |
|
Wu MH, Chen KF, Lin SC, Lgu CW and Tsai SJ: Aberrant expression of leptin in human endometriotic stromal cells is induced by elevated levels of hypoxia inducible factor-1alpha. Am J Pathol. 170:590–598. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Semenza GL: Hif-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol. 13:167–171. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Becker CM, Rohwer N, Funakoshi T, Cramer T, Bernhardt W, Birsner A, Folkman J and D'Amato RJ: 2-Methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis. Am J Pathol. 172:534–544. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Hsiao KY, Chang N, Lin SC, Li YH and Wu MH: Inhibition of dual specificity Phosphatase-2 by hypoxia promotes interleukin-8-mediated angiogenesis in endometriosis. Hum Reprod. 29:2747–2755. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hsiao KY, Chang N, Tsai JL, Lin SC, Tsai SJ and Wu MH: Hypoxia-inhibited DUSP2 expression promotes IL-6/STAT3 signaling in endometriosis. Am J Reprod Immunol. 78:2017.doi: 10.1111/aji.12690. View Article : Google Scholar : PubMed/NCBI | |
|
Sharkey AM, Day K, McPherson A, Malik S, Licence D, Smith SK and Charnock-Jones DS: Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J Clin Endocrinol Metab. 85:402–409. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Kupker W, Schultze-Mosgau A and Diedrich K: Paracrine changes in the peritoneal environment of women with endometriosis. Hum Reprod Update. 4:719–723. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Yang HL, Zhou WJ, Chang KK, Mei J, Huang LQ, Wang MY, Meng Y, Ha SY, Li DJ and Li MQ: The crosstalk between endometrial stromal cells and macrophages impairs cytotoxicity of NK cells in endometriosis by secreting IL-10 and TGF-β. Reproduction. 154:815–825. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
El Hafny-Rahbi B, Brodaczewska K, Collet G, Majewska A, Klimkiewicz K, Delalande A, Grillon C and Kieda C: Tumour angiogenesis normalized by Myo-inositol trispyrophosphate alleviates hypoxia in the microenvironment and promotes antitumor immune response. J Cell Mol Med. 25:3284–3299. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Thiruchelvam U, Dransfield I, Saunders PT and Critchley HO: The importance of the macrophage within the human endometrium. J Leukoc Biol. 93:217–225. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Mehedintu C, Plotogea MN, Ionescu S and Antonovici M: Endometriosis still a challenge. J Med Life. 7:349–357. 2014.PubMed/NCBI | |
|
Matarese G, De Placido G, Nikas Y and Alviggi C: Pathogenesis of endometriosis: Natural immunity dysfunction or autoimmune disease? Trends Mol Med. 9:223–228. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Hogg C, Horne AW and Greaves E: Endometriosis-associated macrophages: Origin, phenotype, and function. Front Endocrinol (Lausanne). 11:72020. View Article : Google Scholar : PubMed/NCBI | |
|
Capobianco A and Rovere-Querini P: Endometriosis, a disease of the macrophage. Front Immunol. 4:92013. View Article : Google Scholar : PubMed/NCBI | |
|
Colette S and Donnez J: Are aromatase inhibitors effective in endometriosis treatment? Expert Opin Investig Drugs. 20:917–931. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Check JH: Chronic pelvic pain syndromes-Traditional and novel therapies: Part I surgical therapy. Clin Exp Obstet Gynecol. 38:10–13. 2011.PubMed/NCBI | |
|
Sivori S, Vitale M, Morelli L, Sanseverino L, Augugliaro R, Bottino C, Moretta L and Moretta A: P46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med. 186:1129–1136. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Freud AG, Zhao S, Wei S, Gitana GM, Molina-Kirsch HF, Atwater SK and Natkunam Y: Expression of the activating receptor, NKp46 (CD335), in human natural killer and T-cell neoplasia. Am J Clin Pathol. 140:853–866. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Cooper MA, Fehniger TA and Caligiuri MA: The biology of human natural killer-cell subsets. Trends Immunol. 22:633–640. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE and Caligiuri MA: Human natural killer cells: A unique innate immunoregulatory role for the CD56(bright) subset. Blood. 97:3146–3151. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Hamerman JA, Ogasawara K and Lanier LL: NK cells in innate immunity. Curr Opin Immunol. 17:29–35. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Vivier E, Tomasello E, Baratin M, Walzer T and Ugolini S: Functions of natural killer cells. Nat Immunol. 9:503–510. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Freud AG, Mundy-Bosse BL, Yu J and Caligiuri MA: The broad spectrum of human natural killer cell diversity. Immunity. 47:820–833. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Reeves RK, Li H, Jost S, Blass E, Li H, Schafer JL, Varner V, Manickam C, Eslamizar L, Altfeld M, et al: Antigen-specific NK cell memory in rhesus macaques. Nat Immunol. 16:927–932. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Hammer Q, Ruckert T and Romagnani C: Natural killer cell specificity for viral infections. Nat Immunol. 19:800–808. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Nikzad R, Angelo LS, Aviles-Padilla K, Le DT, Singh VK, Bimler L, Vukmanovic-Stejic M, Vendrame E, Ranganath T, Simpson L, et al: Human natural killer cells mediate adaptive immunity to viral antigens. Sci Immunol. 4:eaat81162019. View Article : Google Scholar : PubMed/NCBI | |
|
Morvan MG and Lanier LL: Nk cells and cancer: You can teach innate cells new tricks. Nat Rev Cancer. 16:7–19. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Chiossone L, Dumas PY, Vienne M and Vivier E: Natural killer cells and other innate lymphoid cells in cancer. Nat Rev Immunol. 18:671–688. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Raulet DH and Vance RE: Self-tolerance of natural killer cells. Nat Rev Immunol. 6:520–531. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Karre K, Ljunggren HG, Piontek G and Kiessling R: Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 319:675–678. 1986. View Article : Google Scholar : PubMed/NCBI | |
|
Viant C, Fenis A, Chicanne G, Payrastre B, Ugolini S and Vivier E: SHP-1-mediated inhibitory signals promote responsiveness and anti-Tumour functions of natural killer cells. Nat Commun. 5:51082014. View Article : Google Scholar : PubMed/NCBI | |
|
van der Touw W, Chen HM, Pan PY and Chen SH: LILRB Receptor-mediated regulation of myeloid cell maturation and function. Cancer Immunol Immunother. 66:1079–1087. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Stojanovic A, Correia MP and Cerwenka A: The NKG2D/NKG2DL axis in the crosstalk between lymphoid and myeloid cells in health and disease. Front Immunol. 9:8272018. View Article : Google Scholar : PubMed/NCBI | |
|
Zingoni A, Molfetta R, Fionda C, Soriani A, Paolini R, Cippitelli M, Cerboni C and Santoni A: NKG2D and its ligands: ‘One for all, all for one’. Front Immunol. 9:4762018. View Article : Google Scholar : PubMed/NCBI | |
|
Ferlazzo G, Thomas D, Lin SL, Goodman K, Morandi B, Muller WA, Moretta A and Münz C: The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol. 172:1455–1462. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Bryceson YT, March ME, Ljunggren HG and Long EO: Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood. 107:159–166. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Masztalerz A, Van Rooijen N, Den Otter W and Everse LA: Mechanisms of Macrophage cytotoxicity in IL-2 and IL-12 mediated tumour regression. Cancer Immunol Immunother. 52:235–242. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Mukherjee S, Jensen H, Stewart W, Stewart D, Ray WC, Chen SY, Nolan GP, Lanier LL and Das J: In silico modeling identifies CD45 as a regulator of IL-2 synergy in the NKG2D-mediated activation of immature human NK cells. Sci Signal. 10:eaai90622017. View Article : Google Scholar : PubMed/NCBI | |
|
Fehniger TA and Caligiuri MA: Interleukin 15: Biology and relevance to human disease. Blood. 97:14–32. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Kasaian MT, Whitters MJ, Carter LL, Lowe LD, Jussif JM, Deng B, Johnson KA, Witek JS, Senices M, Konz RF, et al: Il-21 limits NK cell responses and promotes Antigen-specific T cell activation: A mediator of the transition from innate to adaptive immunity. Immunity. 16:559–569. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Tarannum M and Romee R: Cytokine-induced memory-like natural killer cells for cancer immunotherapy. Stem Cell Res Ther. 12:5922021. View Article : Google Scholar : PubMed/NCBI | |
|
Marcus A, Mao AJ, Lensink-Vasan M, Wang L, Vance RE and Raulet DH: Tumor-derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response. Immunity. 49:754–763.e4. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lettau M, Paulsen M, Schmidt H and Janssen O: Insights into the molecular regulation of fasl (CD178) biology. Eur J Cell Biol. 90:456–466. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Prager I and Watzl C: Mechanisms of natural killer Cell-mediated cellular cytotoxicity. J Leukoc Biol. 105:1319–1329. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Gazvani R and Templeton A: Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction. 123:217–226. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Ulukus M and Arici A: Immunology of endometriosis. Minerva Ginecol. 57:237–248. 2005.PubMed/NCBI | |
|
Symons LK, Miller JE, Kay VR, Marks RM, Liblik K, Koti M and Tayade C: The immunopathophysiology of endometriosis. Trends Mol Med. 24:748–762. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Oosterlynck DJ, Meuleman C, Waer M, Vandeputte M and Koninckx PR: The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril. 58:290–295. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Maeda N, Izumiya C, Kusum T, Masumoto T, Yamashita C, Yamamoto Y, Oguri H and Fukaya T: Killer inhibitory receptor CD158a overexpression among natural killer cells in women with endometriosis is undiminished by laparoscopic surgery and gonadotropin releasing hormone agonist treatment. Am J Reprod Immunol. 51:364–372. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Vigano P, Vercellini P, Di Blasio AM, Colombo A, Candiani GB and Vignali M: Deficient antiendometrium Lymphocyte-mediated cytotoxicity in patients with endometriosis. Fertil Steril. 56:894–899. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Lotze MT and Rosenberg SA: Results of clinical trials with the administration of interleukin 2 and adoptive immunotherapy with activated cells in patients with cancer. Immunobiology. 172:420–437. 1986. View Article : Google Scholar : PubMed/NCBI | |
|
Sikora J, Smycz-Kubanska M, Mielczarek-Palacz A, Bednarek I and Kondera-Anasz Z: The involvement of multifunctional TGF-β and related cytokines in pathogenesis of endometriosis. Immunol Lett. 201:31–37. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Dias JA Jr, Podgaec S, de Oliveira RM, Carnevale Marin ML, Baracat EC and Abrao MS: Patients with endometriosis of the rectosigmoid have a higher percentage of natural killer cells in peripheral blood. J Minim Invasive Gynecol. 19:317–324. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Oosterlynck DJ, Meuleman C, Lacquet FA, Waer M and Koninckx PR: Flow cytometry analysis of lymphocyte subpopulations in peritoneal fluid of women with endometriosis. Am J Reprod Immunol. 31:25–31. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Vernet-Tomas Mdel M, Perez-Ares CT, Verdu N, Molinero JL, Fernandez-Figueras MT and Carreras R: The endometria of patients with endometriosis show higher expression of Class I human leukocyte antigen than the endometria of healthy women. Fertil Steril. 85:78–83. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Wu MY, Yang JH, Chao KH, Hwang JL, Yang YS and Ho HN: Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis. Fertil Steril. 74:1187–1191. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Matsuoka S, Maeda N, Izumiya C, Yamashita C, Nishimori Y and Fukaya T: Expression of inhibitory-motif killer immunoglobulin-like receptor, KIR2DL1, is increased in natural killer cells from women with pelvic endometriosis. Am J Reprod Immunol. 53:249–254. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Maeda N, Izumiya C, Oguri H, Kusume T, Yamamoto Y and Fukaya T: Aberrant expression of intercellular adhesion Molecule-1 and killer inhibitory receptors induces immune tolerance in women with pelvic endometriosis. Fertil Steril. 77:679–683. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Galandrini R, Porpora MG, Stoppacciaro A, Micucci F, Capuano C, Tassi I, Di Felice A, Benedetti-Panici P and Santoni A: Increased frequency of human leukocyte Antigen-E inhibitory receptor Cd94/Nkg2a-Expressing peritoneal natural killer cells in patients with endometriosis. Fertil Steril. 89 (5 Suppl):S1490–S1496. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Nowak I, Ploski R, Barcz E, Dziunycz P, Kaminski P, Kostrzewa G, Milewski Ł, Roszkowski PI, Senitzer D, Malejczyk J and Kuśnierczyk P: KIR2DS5 in the presence of HLA-C C2 protects against endometriosis. Immunogenetics. 67:203–209. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Guo SW, Du Y and Liu X: Platelet-derived Tgf-Beta1 mediates the Down-modulation of Nkg2d expression and may be responsible for impaired natural Killer (Nk) cytotoxicity in women with endometriosis. Hum Reprod. 31:1462–1474. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Bellelis P, Frediani Barbeiro D, Gueuvoghlanian-Silva BY, Kalil J, Abrao MS and Podgaec S: Interleukin-15 and Interleukin-7 Are the major cytokines to maintain endometriosis. Gynecol Obstet Invest. 84:435–444. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Yu JJ, Sun HT, Zhang ZF, Shi RX, Liu LB, Shang WQ, Wei CY, Chang KK, Shao J, Wang MY and Li MQ: Il15 promotes growth and invasion of endometrial stromal cells and inhibits killing activity of NK cells in endometriosis. Reproduction. 152:151–160. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Gonzalez-Foruria I, Santulli P, Chouzenoux S, Carmona F, Batteux F and Chapron C: Soluble ligands for the NKG2D receptor are released during endometriosis and correlate with disease Severity. PLoS One. 10:e01199612015. View Article : Google Scholar : PubMed/NCBI | |
|
Salih HR, Rammensee HG and Steinle A: Cutting edge: Down-regulation of mica on human tumors by proteolytic shedding. J Immunol. 169:4098–4102. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Salih HR, Goehlsdorf D and Steinle A: Release of micb molecules by tumor cells: Mechanism and soluble micb in sera of cancer patients. Hum Immunol. 67:188–195. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Mazzeo D, Vigano P, Di Blasio AM, Sinigaglia F, Vignali M and Panina-Bordignon P: Interleukin-12 and Its Free P40 subunit regulate immune recognition of endometrial cells: Potential role in endometriosis. J Clin Endocrinol Metab. 83:911–916. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Mei J, Zhou WJ, Zhu XY, Lu H, Wu K, Yang HL, Fu Q, Wei CY, Chang KK, Jin LP, et al: Suppression of Autophagy and HCK Signaling Promotes PTGS2high FCGR3− NK cell differentiation triggered by ectopic endometrial stromal cells. Autophagy. 14:1376–1397. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, Hu Z, Barney KA and Degen JL: Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood. 110:133–141. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Nieswandt B, Hafner M, Echtenacher B and Mannel DN: Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 59:1295–1300. 1999.PubMed/NCBI | |
|
Kopp HG, Placke T and Salih HR: Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res. 69:7775–7783. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Ding D, Liu X and Guo SW: Activated platelets induce estrogen receptor beta expression in endometriotic stromal cells. Gynecol Obstet Invest. 80:187–192. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Binyamin L, Alpaugh RK, Hughes TL, Lutz CT, Campbell KS and Weiner LM: Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy. J Immunol. 180:6392–6401. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Andre P, Denis C, Soulas C, Bourbon-Caillet C, Lopez J, Arnoux T, Bléry M, Bonnafous C, Gauthier L, Morel A, et al: Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells. Cell. 175:1731–1743.e13. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chan EY, Yap DY, Colucci M, Ma AL, Parekh RS and Tullus K: Use of rituximab in childhood idiopathic nephrotic syndrome. Clin J Am Soc Nephrol. 18:533–548. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Sivori S, Della Chiesa M, Carlomagno S, Quatrini L, Munari E, Vacca P, Tumino N, Mariotti FR, Mingari MC, Pende D and Moretta L: Inhibitory receptors and checkpoints in human NK cells, implications for the immunotherapy of cancer. Front Immunol. 11:21562020. View Article : Google Scholar : PubMed/NCBI | |
|
Velasco I, Quereda F, Bermejo R, Campos A and Acien P: Intraperitoneal recombinant Interleukin-2 activates leukocytes in rat endometriosis. J Reprod Immunol. 74:124–132. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Quereda F, Bermejo R, Velasco I, Campos A and Acien P: The effect of intraperitoneal Interleukin-2 on surgically induced endometriosis in rats. Eur J Obstet Gynecol Reprod Biol. 136:243–248. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Dicitore A, Castiglioni S, Saronni D, Gentilini D, Borghi MO, Stabile S, Vignali M, Di Blasio AM, Persani L and Vitale G: Effects of human recombinant type I IFNs (IFN-α2b and IFN-β1a) on growth and migration of primary endometrial stromal cells from women with deeply infiltrating endometriosis: A preliminary study. Eur J Obstet Gynecol Reprod Biol. 230:192–198. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wu MY, Chao KH, Chen SU, Chen HF, Yang YS, Huang SC and Ho HN: The suppression of peritoneal cellular immunity in women with endometriosis could be restored after gonadotropin releasing hormone agonist treatment. Am J Reprod Immunol. 35:510–516. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Regis S, Dondero A, Caliendo F, Bottino C and Castriconi R: NK cell function regulation by TGF-β-induced epigenetic mechanisms. Front Immunol. 11:3112020. View Article : Google Scholar : PubMed/NCBI | |
|
Yoshimura A, Wakabayashi Y and Mori T: Cellular and molecular basis for the regulation of inflammation by TGF-beta. J Biochem. 147:781–792. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Young VJ, Brown JK, Saunders PT, Duncan WC and Horne AW: The peritoneum is both a source and target of TGF-β in women with endometriosis. PLoS One. 9:e1067732014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang M, Xu T, Tong D, Li S, Yu X, Liu B, Jiang L and Liu K: Research advances in endometriosis-related signaling pathways: A review. Biomed Pharmacother. 164:1149092023. View Article : Google Scholar : PubMed/NCBI | |
|
Hawinkels LJ and Ten Dijke P: Exploring Anti-TGF-β therapies in cancer and fibrosis. Growth Factors. 29:140–152. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Voelker J, Berg PH, Sheetz M, Duffin K, Shen T, Moser B, Greene T, Blumenthal SS, Rychlik I, Yagil Y, et al: Anti-TGF-β1 antibody therapy in patients with diabetic nephropathy. J Am Soc Nephrol. 28:953–962. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Clayton RD, Duffy SR, Wilkinson N, Garry R and Jackson AM: Increase in peripheral blood mononuclear cell (PBMC)- and CD56+ cell-mediated killing of endometrial stromal cells by mycobacteria; a possible role in endometriosis immunotherapy? Hum Reprod. 19:1886–1893. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Oksasoglu B, Hepokur C, Misir S, Yildiz C, Sonmez G and Yanik A: Determination of PD-1 expression in peripheral blood cells in patients with endometriosis. Gynecol Endocrinol. 37:157–161. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wu L, Lv C, Su Y, Li C, Zhang H, Zhao X and Li M: Expression of programmed death-1 (PD-1) and Its Ligand PD-L1 is upregulated in endometriosis and promoted by 17beta-estradiol. Gynecol Endocrinol. 35:251–256. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Z, Yang Y, Liu LL and Lundqvist A: Strategies to augment natural killer (NK) cell activity against solid tumors. Cancers (Basel). 11:10402019. View Article : Google Scholar : PubMed/NCBI | |
|
Memon H and Patel BM: Immune checkpoint inhibitors in non-small cell lung cancer: A Bird's eye view. Life Sci. 233:1167132019. View Article : Google Scholar : PubMed/NCBI | |
|
Giannopoulos K: Targeting immune signaling checkpoints in acute myeloid leukemia. J Clin Med. 8:2362019. View Article : Google Scholar : PubMed/NCBI | |
|
Hofmann L, Forschner A, Loquai C, Goldinger SM, Zimmer L, Ugurel S, Schmidgen MI, Gutzmer R, Utikal JS, Göppner D, et al: Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of Anti-PD-1 therapy. Eur J Cancer. 60:190–209. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sosa A, Lopez Cadena E, Simon Olive C, Karachaliou N and Rosell R: Clinical assessment of immune-related adverse events. Ther Adv Med Oncol. 10:17588359187646282018. View Article : Google Scholar : PubMed/NCBI | |
|
Afolabi LO, Adeshakin AO, Sani MM, Bi J and Wan X: Genetic reprogramming for NK cell cancer immunotherapy with CRISPR/Cas9. Immunology. 158:63–69. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Dou M, Ma Q, Yao R and Liu J: Chimeric antigen receptor (CAR)-modified NK cells against cancer: Opportunities and challenges. Int Immunopharmacol. 74:1056952019. View Article : Google Scholar : PubMed/NCBI | |
|
Kloess S, Kretschmer A, Stahl L, Fricke S and Koehl U: CAR-expressing natural killer cells for cancer retargeting. Transfus Med Hemother. 46:4–13. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Seshadri S and Sunkara SK: Natural killer cells in female infertility and recurrent miscarriage: A systematic review and meta-analysis. Hum Reprod Update. 20:429–438. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hadinedoushan H, Mirahmadian M and Aflatounian A: Increased natural killer cell cytotoxicity and Il-2 production in recurrent spontaneous abortion. Am J Reprod Immunol. 58:409–414. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, Becker CD, See P, Price J, Lucas D, et al: Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 38:792–804. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L, Garner H, Trouillet C, de Bruijn MF, Geissmann F and Rodewald HR: Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature. 518:547–551. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Gordon S and Martinez FO: Alternative activation of macrophages: Mechanism and functions. Immunity. 32:593–604. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, de Waal-Malefyt R and Ottenhoff TH: Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA. 101:4560–4565. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Bonatz G, Hansmann ML, Buchholz F, Mettler L, Radzun HJ and Semm K: Macrophage- and lymphocyte-subtypes in the endometrium during different phases of the ovarian cycle. Int J Gynaecol Obstet. 37:29–36. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Vallve-Juanico J, Santamaria X, Vo KC, Houshdaran S and Giudice LC: Macrophages display proinflammatory phenotypes in the eutopic endometrium of women with endometriosis with relevance to an infectious etiology of the disease. Fertil Steril. 112:1118–1128. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Maybin JA and Critchley HO: Menstrual physiology: Implications for endometrial pathology and beyond. Hum Reprod Update. 21:748–761. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Bain CC and Jenkins SJ: The biology of serous cavity macrophages. Cell Immunol. 330:126–135. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Hudson QJ, Ashjaei K, Perricos A, Kuessel L, Husslein H, Wenzl R and Yotova I: Endometriosis patients show an increased M2 response in the peritoneal CD14+low/CD68+low macrophage subpopulation coupled with an increase in the T-helper 2 and T-regulatory cells. Reprod Sci. 27:1920–1931. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Roszer T: Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediators Inflamm. 2015:8164602015. View Article : Google Scholar : PubMed/NCBI | |
|
Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A and Locati M: The Chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:677–686. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Bardi GT, Smith MA and Hood JL: Melanoma exosomes promote mixed M1 and M2 macrophage polarization. Cytokine. 105:63–72. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Simpson JL, Elias S, Malinak LR and Buttram VC Jr: Heritable aspects of Endometriosis. I. Genetic studies. Am J Obstet Gynecol. 137:327–331. 1980. View Article : Google Scholar : PubMed/NCBI | |
|
Dmowski WP, Gebel H and Braun DP: Decreased apoptosis and sensitivity to macrophage mediated cytolysis of endometrial cells in endometriosis. Hum Reprod Update. 4:696–701. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Wu MH, Shoji Y, Wu MC, Chuang PC, Lin CC, Huang MF and Tsai SJ: Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis. Am J Pathol. 167:1061–1069. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Gou Y, Li X, Li P, Zhang H, Xu T, Wang H, Wang B, Ma X, Jiang X and Zhang Z: Estrogen receptor β upregulates CCL2 via NF-κB signaling in endometriotic stromal cells and recruits macrophages to promote the pathogenesis of endometriosis. Hum Reprod. 34:646–658. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kwon MJ, Shin HY, Cui Y, Kim H, Thi AH, Choi JY, Kim EY, Hwang DH and Kim BG: CCL2 mediates neuron-macrophage interactions to drive proregenerative macrophage activation following preconditioning injury. J Neurosci. 35:15934–15947. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Johan MZ, Ingman WV, Robertson SA and Hull ML: Macrophages infiltrating endometriosis-like lesions exhibit progressive phenotype Changes in a heterologous mouse model. J Reprod Immunol. 132:1–8. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Bacci M, Capobianco A, Monno A, Cottone L, Di Puppo F, Camisa B, Mariani M, Brignole C, Ponzoni M, Ferrari S, et al: Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol. 175:547–556. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Huang YJ, Yang CK, Wei PL, Huynh TT, Whang-Peng J, Meng TC, Hsiao M, Tzeng YM, Wu AT and Yen Y: Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 Tumor-associated macrophages through YAP oncogenic pathways. J Hematol Oncol. 10:602017. View Article : Google Scholar : PubMed/NCBI | |
|
Monsivais D, Dyson MT, Yin P, Coon JS, Navarro A, Feng G, Malpani SS, Ono M, Ercan CM, Wei JJ, et al: ERβ- and prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth inhibitor in endometriosis. Mol Endocrinol. 28:1304–1315. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Han SJ, Jung SY, Wu SP, Hawkins SM, Park MJ, Kyo S, Qin J, Lydon JP, Tsai SY, Tsai MJ, et al: Estrogen receptor β modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell. 163:960–974. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Stanojevic S, Curuvija I, Blagojevic V, Petrovic R, Prijic I and Vujic V: The involvement of estrogen receptors α and β in the in vitro effects of 17β-estradiol on secretory profile of peritoneal macrophages from naturally menopausal female and middle-aged male rats. Exp Gerontol. 113:86–94. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao Y, Gong P, Chen Y, Nwachukwu JC, Srinivasan S, Ko C, Bagchi MK, Taylor RN, Korach KS, Nettles KW, et al: Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis. Sci Transl Med. 7:271ra92015. View Article : Google Scholar : PubMed/NCBI | |
|
Panchanathan R, Shen H, Zhang X, Ho SM and Choubey D: Mutually positive regulatory feedback loop between interferons and estrogen receptor-alpha in mice: Implications for sex bias in autoimmunity. PLoS One. 5:e108682010. View Article : Google Scholar : PubMed/NCBI | |
|
Smith S, Ni Gabhann J, McCarthy E, Coffey B, Mahony R, Byrne JC, Stacey K, Ball E, Bell A, Cunnane G, et al: Estrogen receptor α regulates tripartite motif-containing protein 21 expression, contributing to dysregulated cytokine production in systemic lupus erythematosus. Arthritis Rheumatol. 66:163–172. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Feldman I, Feldman GM, Mobarak C, Dunkelberg JC and Leslie KK: Identification of proteins within the nuclear factor-kappa B transcriptional complex including estrogen receptor-alpha. Am J Obstet Gynecol. 196:394.e1–13. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Kalaitzidis D and Gilmore TD: Transcription factor cross-talk: The estrogen receptor and NF-kappaB. Trends Endocrinol Metab. 16:46–52. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Greaves E, Temp J, Esnal-Zufiurre A, Mechsner S, Horne AW and Saunders PT: Estradiol is a critical mediator of macrophage-nerve cross talk in peritoneal endometriosis. Am J Pathol. 185:2286–2297. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Gaudet HM, Cheng SB, Christensen EM and Filardo EJ: The G-protein coupled estrogen receptor, gper: The inside and inside-out story. Mol Cell Endocrinol. 418:207–219. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Revankar CM, Cimino DF, Sklar LA, Arterburn JB and Prossnitz ER: A Transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 307:1625–1630. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Heublein S, Lenhard M, Vrekoussis T, Schoepfer J, Kuhn C, Friese K, Makrigiannakis A, Mayr D and Jeschke U: The G-protein-coupled estrogen receptor (GPER) is expressed in normal human ovaries and is upregulated in ovarian endometriosis and pelvic inflammatory disease involving the ovary. Reprod Sci. 19:1197–1204. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Okamoto M, Suzuki T, Mizukami Y and Ikeda T: The Membrane-type estrogen receptor G-protein-coupled estrogen receptor suppresses lipopolysaccharide-induced interleukin 6 via inhibition of nuclear factor-kappa B pathway in murine macrophage cells. Anim Sci J. 88:1870–1879. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Calippe B, Douin-Echinard V, Delpy L, Laffargue M, Lelu K, Krust A, Pipy B, Bayard F, Arnal JF, Guéry JC and Gourdy P: 17Beta-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor alpha signaling in macrophages in vivo. J Immunol. 185:1169–1176. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang YH, He M, Wang Y and Liao AH: Modulators of the balance between M1 and M2 macrophages during pregnancy. Front Immunol. 8:1202017.PubMed/NCBI | |
|
Chen S, Liu Y, Zhong Z, Wei C, Liu Y and Zhu X: Peritoneal immune microenvironment of endometriosis: Role and therapeutic perspectives. Front Immunol. 14:11346632023. View Article : Google Scholar : PubMed/NCBI | |
|
Hirata T, Osuga Y, Takamura M, Kodama A, Hirota Y, Koga K, Yoshino O, Harada M, Takemura Y, Yano T and Taketani Y: Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells. Endocrinology. 151:5468–5476. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Buerger C, Shirsath N, Lang V, Berard A, Diehl S, Kaufmann R, Boehncke WH and Wolf P: Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation. PLoS One. 12:e01808532017. View Article : Google Scholar : PubMed/NCBI | |
|
Schenken RS, Johnson JV and Riehl RM: C-myc protooncogene polypeptide expression in endometriosis. Am J Obstet Gynecol. 164:1031–1037. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Selam B, Kayisli UA, Garcia-Velasco JA, Akbas GE and Arici A: Regulation of Fas ligand expression by IL-8 in human endometrium. J Clin Endocrinol Metab. 87:3921–3927. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Gazvani MR, Christmas S, Quenby S, Kirwan J, Johnson PM and Kingsland CR: Peritoneal fluid concentrations of interleukin-8 in women with endometriosis: Relationship to stage of disease. Human Reproduction. 13:1957–1961. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Borrelli GM, Abrao MS and Mechsner S: Can chemokines be used as biomarkers for endometriosis? A systematic review. Hum Reprod. 29:253–266. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Schneider J, Jimenez E, Rodriguez F and del Tanago JG: c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis. Oncol Rep. 5:49–52. 1998.PubMed/NCBI | |
|
Capobianco A, Monno A, Cottone L, Venneri MA, Biziato D, Di Puppo F, Ferrari S, De Palma M, Manfredi AA and Rovere-Querini P: Proangiogenic Tie2(+) macrophages infiltrate human and murine endometriotic lesions and dictate their growth in a mouse model of the disease. Am J Pathol. 179:2651–2659. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kats R, Collette T, Metz CN and Akoum A: Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis. Fertil Steril. 78:69–76. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Akoum A, Metz CN, Al-Akoum M and Kats R: Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status, and pelvic pain. Fertil Steril. 85:1379–1385. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Morin M, Bellehumeur C, Therriault MJ, Metz C, Maheux R and Akoum A: Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis. Fertil Steril. 83:865–872. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Kats R, Metz CN and Akoum A: Macrophage migration inhibitory factor is markedly expressed in active and early-stage endometriotic lesions. J Clin Endocrinol Metab. 87:883–889. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Seeber B, Sammel MD, Fan X, Gerton GL, Shaunik A, Chittams J and Barnhart KT: Panel of markers can accurately predict endometriosis in a subset of patients. Fertil Steril. 89:1073–1081. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Zinovkin DA, Pranjol MZI, Bilsky IA and Zmushko VA: Tumor-associated T-lymphocytes and macrophages are decreased in endometrioid endometrial carcinoma with melf-pattern stromal changes. Cancer Microenviron. 11:107–114. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Jha P, Farooq A, Agarwal N and Buckshee K: In vitro sperm phagocytosis by human peritoneal macrophages in endometriosis-associated infertility. Am J Reprod Immunol. 36:235–237. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Forster R, Sarginson A, Velichkova A, Hogg C, Dorning A, Horne AW, Saunders PTK and Greaves E: Macrophage-derived insulin-like growth Factor-1 is a key neurotrophic and nerve-sensitizing factor in pain associated with endometriosis. FASEB J. 33:11210–11222. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Bushnell LF: Endometriosis and estrogen therapy. Am J Obstet Gynecol. 55:9151948. View Article : Google Scholar | |
|
Barbieri RL: Endometriosis and the estrogen threshold theory. Relation to surgical and medical treatment. J Reprod Med. 43 (3 Suppl):S287–S292. 1998. | |
|
Howell R, Dowsett M, King N and Edmonds DK: Endocrine effects of gnrh analogue with low-dose hormone replacement therapy in women with endometriosis. Clin Endocrinol (Oxf). 43:609–615. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Chang CY, Chiang AJ, Yan MJ, Lai MT, Su YY, Huang HY, Chang CY, Li YH, Li PF, Chen CM, et al: Ribosome biogenesis serves as a therapeutic target for treating endometriosis and the associated complications. Biomedicines. 10:1852022. View Article : Google Scholar : PubMed/NCBI | |
|
Khoufache K, Bazin S, Girard K, Guillemette J, Roy MC, Verreault JP, Al-Abed Y, Foster W and Akoum A: Macrophage migration inhibitory factor antagonist blocks the development of endometriosis in vivo. PLoS One. 7:e372642012. View Article : Google Scholar : PubMed/NCBI | |
|
Daha MR: Role of complement in innate immunity and infections. Crit Rev Immunol. 30:47–52. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Conigliaro P, Triggianese P, Ballanti E, Perricone C, Perricone R and Chimenti MS: Complement, infection, and autoimmunity. Curr Opin Rheumatol. 31:532–541. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Trouw LA, Blom AM and Gasque P: Role of complement and complement regulators in the removal of apoptotic cells. Mol Immunol. 45:1199–1207. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Hajishengallis G, Reis ES, Mastellos DC, Ricklin D and Lambris JD: Novel mechanisms and functions of complement. Nat Immunol. 18:1288–1298. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Lubbers R, van Essen MF, van Kooten C and Trouw LA: Production of complement components by cells of the immune system. Clin Exp Immunol. 188:183–194. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Merle NS, Church SE, Fremeaux-Bacchi V and Roumenina LT: Complement system part I-molecular mechanisms of activation and regulation. Front Immunol. 6:2622015. View Article : Google Scholar : PubMed/NCBI | |
|
Merle NS, Noe R, Halbwachs-Mecarelli L, Fremeaux-Bacchi V and Roumenina LT: Complement system part II: Role in immunity. Front Immunol. 6:2572015. View Article : Google Scholar : PubMed/NCBI | |
|
Ricklin D, Reis ES and Lambris JD: Complement in disease: A defence system turning offensive. Nat Rev Nephrol. 12:383–401. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang T, De Carolis C, Man GCW and Wang CC: The Link between Immunity, autoimmunity and endometriosis: A literature update. Autoimmunity Revi. 17:945–955. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Aslan C, Ak H, Askar N, Ozkaya AB, Ergenoglu AM, Yeniel AO, Akdemir A and Aydin HH: Overexpression of complement C5 in endometriosis. Clin Biochem. 47:496–498. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Rahal D, Andrade F and Nisihara R: Insights into the role of complement system in the pathophysiology of endometriosis. Immunol Lett. 231:43–48. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Kabut J, Kondera-Anasz Z, Sikora J and Mielczarek-Palacz A: Levels of complement components iC3b, C3c, C4, and SC5b-9 in peritoneal fluid and serum of infertile women with endometriosis. Fertil Steril. 88:1298–1303. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Sikora J, Wroblewska-Czech A, Smycz-Kubanska M, Mielczarek-Palacz A, Cygal A, Witek A and Kondera-Anasz Z: The role of complement components C1q, MBL and C1 inhibitor in pathogenesis of endometriosis. Arch Gynecol Obstet. 297:1495–1501. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ahn SH, Khalaj K, Young SL, Lessey BA, Koti M and Tayade C: Immune-inflammation gene signatures in endometriosis patients. Fertil Steril. 106:1420–1431.e7. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Weed JC and Arquembourg PC: Endometriosis: Can it produce an autoimmune response resulting in infertility? Clin Obstet Gynecol. 23:885–893. 1980. View Article : Google Scholar : PubMed/NCBI | |
|
Isaacson KB, Coutifaris C, Garcia CR and Lyttle CR: Production and secretion of complement component-3 by endometriotic tissue. J Clin Endocrinol Metab. 69:1003–1009. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Badawy SZA, Cuenca V, Stitzel A, Jacobs RDB and Tomar RH: Autoimmune phenomena in infertile patients with endometriosis. Obstet Gynecol. 63:271–275. 1984.PubMed/NCBI | |
|
Badawy SZA, Cuenca V, Marshall L, Munchback R, Rinas AC and Coble DA: Cellular-components in peritoneal-fluid in infertile patients with and without endometriosis. Fertil Steril. 42:704–708. 1984. View Article : Google Scholar : PubMed/NCBI | |
|
Tao XJ, Sayegh RA and Isaacson KB: Increased expression of complement component 3 in human ectopic endometrium compared with the matched eutopic endometrium. Fertil Steril. 68:460–467. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Sayegh RA, Tao XJ, Awwad JT and Isaacson KB: Localization of the expression of complement component 3 in the human endometrium by in situ hybridization. J Clin Endocrinol Metab. 81:1641–1649. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Steele RW, Dmowski WP and Marmer DJ: Immunological aspects of human endometriosis. Am J Reprod Immunol (1980). 6:33–36. 1984. View Article : Google Scholar : PubMed/NCBI | |
|
Meek SC, Hodge DD and Musich JR: Autoimmunity in infertile patients with endometriosis. Am J Obstet Gynecol. 158:1365–1373. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Isaacson KB, Galman M, Coutifaris C and Lyttle CR: Endometrial synthesis and secretion of complement component-3 by patients with and without endometriosis. Fertil Steril. 53:836–841. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Hasan A, Rahim A, Afzal M, Naveed AK, Ayub S and Jahan S: Serum albumin and C3 complement levels in endometriosis. J Coll Physicians Surg Pak. 29:702–705. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Bischof P, Planasbasset D, Campana A and Meisser A: Investigations on the cell type responsible for the endometrial secretion of complement component-3 (C3). Human Reprod. 9:1652–1659. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Liu CF, Min XY, Wang N, Wang JX, Ma N, Dong X, Zhang B, Wu W, Li ZF, Zhou W and Li K: Complement receptor 3 Has negative impact on tumor surveillance through suppression of natural killer cell function. Front Immunol. 8:16022017. View Article : Google Scholar : PubMed/NCBI | |
|
Suryawanshi S, Huang X, Elishaev E, Budiu RA, Zhang L, Kim S, Donnellan N, Mantia-Smaldone G, Ma T, Tseng G, et al: Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res. 20:6163–6174. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Woelfler MM, Meinhold-Heerlein IM, Soehngen L, Rath W, Knuechel R, Neulen J, Maass N and Henkel C: Two-dimensional gel electrophoresis in peritoneal fluid samples identifies differential protein regulation in patients suffering from peritoneal or ovarian endometriosis. Fertil Steril. 95:2764–2768. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Riley CF, Moen MH and Videm V: Inflammatory markers in endometriosis: Reduced peritoneal neutrophil response in minimal endometriosis. Acta Obstet Gynecol Scand. 86:877–881. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Kruse C, Steffensen R, Nielsen HJ and Jensenius JC: Mannan-binding lectin polymorphisms and serum levels in patients with endometriosis. Eur J Obstet Gynecol Reprod Biol. 181:256–258. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kruse C, Steffensen R, Nielsen HJ and Jensenius JC: Mannan-binding lectin polymorphisms and serum levels in patients with endometriosis. Eur J Obstet Gynecol Reprod Biol. 181:256–258. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kavoussi SK, Mueller MD and Lebovic DI: Expression of mannose-binding lectin in the peritoneal fluid of women with and without endometriosis. Fertil Steril. 85:1526–1528. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Ozerkan K, Oral B and Uncu G: Mannose-binding lectin levels in endometriosis. Fertil Steril. 94:775–776. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Karadadas E, Hortu I, Ak H, Ergenoglu AM, Karadadas N and Aydin HH: Evaluation of complement system proteins C3a, C5a and C6 in patients of endometriosis. Clin Biochem. 81:15–19. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Stefkovich ML, Arao Y, Hamilton KJ and Korach KS: Experimental models for evaluating non-genomic estrogen signaling. Steroids. 133:34–37. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Al-Sabbagh M, Lam EW and Brosens JJ: Mechanisms of endometrial progesterone resistance. Mol Cell Endocrinol. 358:208–215. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Han SJ and O'Malley BW: The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis. Hum Reprod Update. 20:467–484. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Patel BG, Rudnicki M, Yu J, Shu Y and Taylor RN: Progesterone resistance in endometriosis: Origins, consequences and interventions. Acta Obstet Gynecol Scand. 96:623–632. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H and Chambon P: Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9:1603–1614. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Patel B, Elguero S, Thakore S, Dahoud W, Bedaiwy M and Mesiano S: Role of Nuclear progesterone receptor isoforms in uterine pathophysiology. Hum Reprod Update. 21:155–173. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Vasquez YM and DeMayo FJ: Role of nuclear receptors in blastocyst implantation. Semin Cell Dev Biol. 24:724–735. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chantalat E, Valera MC, Vaysse C, Noirrit E, Rusidze M, Weyl A, Vergriete K, Buscail E, Lluel P, Fontaine C, et al: Estrogen receptors and endometriosis. Int J Mol Sci. 21:28152020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Zhu L, Kuokkanen S and Pollard JW: Activation of protein synthesis in mouse uterine epithelial cells by estradiol-17β is mediated by a PKC-ERK1/2-mTOR signaling pathway. Proc Natl Acad Sci USA. 112:E1382–E1391. 2015.PubMed/NCBI | |
|
Reis FM, Petraglia F and Taylor RN: Endometriosis: Hormone regulation and clinical consequences of chemotaxis and apoptosis. Hum Reprod Update. 19:406–418. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yilmaz BD and Bulun SE: Endometriosis and nuclear receptors. Hum Reprod Update. 25:473–485. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Xue Q, Lin Z, Cheng YH, Huang CC, Marsh E, Yin P, Milad MP, Confino E, Reierstad S, Innes J and Bulun SE: Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod. 77:681–687. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Trukhacheva E, Lin Z, Reierstad S, Cheng YH, Milad M and Bulun SE: Estrogen receptor (ER) beta regulates eralpha expression in stromal cells derived from ovarian endometriosis. J Clin Endocrinol Metab. 94:615–622. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Bulun SE, Yilmaz BD, Sison C, Miyazaki K, Bernardi L, Liu S, Kohlmeier A, Yin P, Milad M and Wei J: Endometriosis. Endocr Rev. 40:1048–1079. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR, Lessey BA and Giudice LC: Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology. 148:3814–3826. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Flores VA, Vanhie A, Dang T and Taylor HS: Progesterone receptor status predicts response to progestin therapy in endometriosis. J Clin Endocrinol Metab. 103:4561–4568. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Broi MGD, Rocha CVJ, Meola J, Martins WP, Carvalho FM, Ferriani RA and Navarro PA: Expression of PGR, HBEGF, ITGAV, ITGB3 and SPP1 genes in eutopic endometrium of infertile women with endometriosis during the implantation window: A pilot study. JBRA Assist Reprod. 21:196–202. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Strowitzki T, Marr J, Gerlinger C, Faustmann T and Seitz C: Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: A 24-Week, randomized, multicentre, open-label trial. Hum Reprod. 25:633–641. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Saunders PTK and Horne AW: Endometriosis: Etiology, pathobiology, and therapeutic prospects. Cell. 184:2807–2824. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Ferrero S, Evangelisti G and Barra F: Current and emerging treatment options for endometriosis. Expert Opin Pharmacother. 19:1109–1125. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Capezzuoli T, Rossi M, La Torre F, Vannuccini S and Petraglia F: Hormonal drugs for the treatment of endometriosis. Curr Opin Pharmacol. 67:1023112022. View Article : Google Scholar : PubMed/NCBI | |
|
Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, et al: ESHRE guideline: Management of women with endometriosis. Hum Reprod. 29:400–412. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Crosignani PG, Luciano A, Ray A and Bergqvist A: Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod. 21:248–256. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Selak V, Farquhar C, Prentice A and Singla A: Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev. CD0000682007.PubMed/NCBI | |
|
Strowitzki T, Faustmann T, Gerlinger C and Seitz C: Dienogest in the treatment of endometriosis-associated pelvic pain: A 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 151:193–198. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Petaja J: Inflammation and coagulation. An overview. Thromb Res. 127 (Suppl 2):S34–S37. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Demetz G and Ott I: The interface between inflammation and coagulation in cardiovascular disease. Int J Inflam. 2012:8603012012.PubMed/NCBI | |
|
Lessey BA, Castelbaum AJ, Sawin SW, Buck CA, Schinnar R, Bilker W and Strom BL: Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab. 79:643–649. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Regidor PA, Vogel C, Regidor M, Schindler AE and Winterhager E: Expression pattern of integrin adhesion molecules in endometriosis and human endometrium. Hum Reprod Update. 4:710–718. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Libersan D and Merhi Y: Platelet P-selectin expression: Requirement for protein kinase C, but not protein tyrosine kinase or phosphoinositide 3-kinase. Thromb Haemost. 89:1016–1023. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Guo SW, Ding D, Geng JG, Wang L and Liu X: P-selectin as a potential therapeutic target for endometriosis. Fertil Steril. 103:990–1000.e8. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lorant DE, Patel KD, McIntyre TM, McEver RP, Prescott SM and Zimmerman GA: Coexpression of Gmp-140 and paf by endothelium stimulated by histamine or thrombin: A juxtacrine system for adhesion and activation of neutrophils. J Cell Biol. 115:223–234. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Lefer DJ: Pharmacology of selectin inhibitors in ischemia/reperfusion states. Annu Rev Pharmacol Toxicol. 40:283–294. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Kling D, Stucki C, Kronenberg S, Tuerck D, Rheaume E, Tardif JC, Gaudreault J and Schmitt C: Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab-preclinical and clinical studies. Thromb Res. 131:401–410. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Harada T and Taniguchi F: Dienogest: A new therapeutic agent for the treatment of endometriosis. Womens Health (Lond). 6:27–35. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kaminski K, Fiegler P, Marr J and Moore C: Treatment of endometriosis with dienogest: Preliminary report. Ginekol Pol. 72:299–304. 2001.(In Polish). PubMed/NCBI | |
|
Harada T, Momoeda M, Taketani Y, Aso T, Fukunaga M, Hagino H and Terakawa N: Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis-a randomized, double-blind, multicenter, controlled trial. Fertil Steril. 91:675–681. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Rother RP, Rollins SA, Mojcik CF, Brodsky RA and Bell L: Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. Nat Biotechnol. 25:1256–1264. 2007. View Article : Google Scholar : PubMed/NCBI |
